Molecular Cancer Therapeutics CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butt, A. J.
Right arrow Articles by Sutherland, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butt, A. J.
Right arrow Articles by Sutherland, R. L.
Mol Cancer Ther. 2006;5:2300-2309
© 2006 American Association for Cancer Research

Research Articles: Therapeutics

A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells

Alison J. Butt1,2, Caroline G. Roberts1, Alan A. Seawright3, Peter B. Oelrichs3, John K. MacLeod4, Tracy Y.E. Liaw5, Maria Kavallaris5, Tiffany J. Somers-Edgar1, Gillian M. Lehrbach1, Colin K. Watts1 and Robert L. Sutherland1,2

1 Cancer Research Program, Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, New South Wales, Australia; 2 St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia; 3 National Research Centre for Environmental Toxicology, University of Queensland, Brisbane, Queensland, Australia; 4 Research School of Chemistry, Australian National University, Canberra, Australian Capital Territory, Australia; and 5 Children's Cancer Institute Australia for Medical Research, Randwick, New South Wales, Australia

Requests for reprints: Alison J. Butt, Cancer Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Vales 2010, Australia. Phone: 612-9295-8327; Fax: 612-9295-8321. E-mail: abutt{at}garvan.org.au

Phytochemicals have provided an abundant and effective source of therapeutics for the treatment of cancer. Here we describe the characterization of a novel plant toxin, persin, with in vivo activity in the mammary gland and a p53-, estrogen receptor–, and Bcl-2-independent mode of action. Persin was previously identified from avocado leaves as the toxic principle responsible for mammary gland–specific necrosis and apoptosis in lactating livestock. Here we used a lactating mouse model to confirm that persin has a similar cytotoxicity for the lactating mammary epithelium. Further in vitro studies in a panel of human breast cancer cell lines show that persin selectively induces a G2-M cell cycle arrest and caspase-dependent apoptosis in sensitive cells. The latter is dependent on expression of the BH3-only protein Bim. Bim is a sensor of cytoskeletal integrity, and there is evidence that persin acts as a microtubule-stabilizing agent. Due to the unique structure of the compound, persin could represent a novel class of microtubule-targeting agent with potential specificity for breast cancers. [Mol Cancer Ther 2006;5(9):2300–9]


Grant support: U.S. Department of Defense Breast Cancer Research Program grants DAMD17-03-1-0668 and DAMD17-00-1-0622, Cancer Institute NSW Career Development and Support Fellowship (A.J. Butt), and National Health and Medical Research Council RD Wright Career Development Award (M. Kavallaris).

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

6 A.A. Seawright, personal communication.

Received 3/29/06; revised 6/25/06; accepted 7/12/06.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. R. Khawaja, M. Carre, H. Kovacic, M. A. Esteve, and D. Braguer
Patupilone-Induced Apoptosis Is Mediated by Mitochondrial Reactive Oxygen Species through Bim Relocalization to Mitochondria
Mol. Pharmacol., October 1, 2008; 74(4): 1072 - 1083.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. G. Roberts, E. Gurisik, T. J. Biden, R. L. Sutherland, and A. J. Butt
Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism
Mol. Cancer Ther., October 1, 2007; 6(10): 2777 - 2785.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.